Barrier Reverse Convertible

Symbol: ABCISQ
ISIN: CH1282381792
Issuer:
Swissquote Bank SA
Trade

Chart

    
    

SIX Structured Products trading

SIX Structured Products Bid Ask Notation
Please note that data is only available after start of trading.

Performance

Closing prev. day 85.20
Diff. absolute / % -1.93 -2.22%

Determined prices

Last Price 94.93 Volume 5,000
Time 14:25:38 Date 12/11/2024

More Product Information

Core Data

Name Barrier Reverse Convertible
ISIN CH1282381792
Valor 128238179
Symbol ABCISQ
Quotation in percent Yes
Coupon p.a. 12.08%
Coupon Premium 10.71%
Coupon Yield 1.37%
Type Multi Barrier Reverse Convertibles
SVSP Code 1230
Barrier reached No
COSI Product No
Exercise type American
Currency Swiss Franc
First Trading Date 18/12/2023
Date of maturity 18/03/2025
Last trading day 10/03/2025
Settlement Type Path-dependent
IRS 871m Potentially in scope for combined transactions
Currency safeguarded Yes
Pricing Dirty
Issuer Swissquote Bank SA

Key data

Ask Price (basis for calculation) 85.5200
Maximum yield 23.98%
Maximum yield p.a. 75.47%
Sideways yield 23.98%
Sideways yield p.a. 75.47%

market maker quality Date: 20/11/2024

Average Spread 0.90%
Last Best Bid Price 86.33 %
Last Best Ask Price 87.13 %
Last Best Bid Volume 250,000
Last Best Ask Volume 250,000
Average Buy Volume 250,000
Average Sell Volume 250,000
Average Buy Value 221,283 CHF
Average Sell Value 223,283 CHF
Spreads Availability Ratio 99.94%
Quote Availability 99.94%

Underlyings

Name Pfizer Inc. Roche AG Bayer AG
ISIN US7170811035 CH0012032048 DE000BAY0017
Price 24.57 EUR 254.30 CHF 19.844 EUR
Date 22/11/24 22:59 22/11/24 17:30 22/11/24 22:58
Cap 28.78 USD 253.30 CHF 31.895 EUR
Distance to Cap -3.15 1.2 -12.187
Distance to Cap in % -12.29% 0.47% -61.84%
Is Cap Level reached No No No
Barrier 15.829 USD 139.315 CHF 17.5423 EUR
Distance to Barrier 9.801 115.185 2.1657
Distance to Barrier in % 38.24% 45.26% 10.99%
Is Barrier reached No No No

Please wait...
The data push was deactivated due to a timeout. Please click "Refresh page" to continue.